Zhan Chao Liang

Director de Inversiones en Shanghai Med-Fine Asset Management Co. Ltd. .

40 años

Consumer Services

Health Technology

Perfil

Zhan Chao Liang is currently the Director at Beijing Mabworks Biotech Co., Ltd.
and the Chief Investment Officer & Partner at Shanghai Med-Fine Asset Management Co. Ltd.
He completed his undergraduate degree from Hlj August First Land Reclamation University in 2008 and his graduate degree from the Academy of Military Medical Sciences in 2011.

Cargos activos de Zhan Chao Liang

Empresas	Cargo	Inicio
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Director/Miembro de la Junta	01/05/2016
Shanghai Med-Fine Asset Management Co. Ltd.	Director de Inversiones	01/04/2015

Todos los cargos activos de Zhan Chao Liang

Formación de Zhan Chao Liang.

Hlj August First Land Reclamation University	Undergraduate Degree
Academy of Military Medical Sciences	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Zhan Chao Liang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Health Technology
Shanghai Med-Fine Asset Management Co. Ltd.